<i>In vitro</i> and <i>in vivo</i> identification of clinically approved drugs that modify <i> <scp>ACE</scp> 2 </i> expression
The COVID-19 pandemic caused by SARS-CoV-2 has is a global health challenge. Angiotensin-converting enzyme 2 (ACE2) is the host receptor for SARS-CoV-2 entry. Recent studies have suggested that patients with hypertension and diabetes treated with ACE inhibitors (ACEIs) or angiotensin receptor blocke...
-д хадгалсан:
Үндсэн зохиолчид: | , , , , , |
---|---|
Формат: | Artigo |
Хэл сонгох: | англи |
Хэвлэсэн: |
2020
|
Онлайн хандалт: | https://doi.org/10.15252/msb.20209628 |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|